These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM. Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [Abstract] [Full Text] [Related]
3. Medical management of patients with difficult-to-treat inflammatory bowel disease. van Hogezand RA. Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006 [Abstract] [Full Text] [Related]
10. Current status of drug therapy for inflammatory bowel disease. Peppercorn MA. Compr Ther; 1985 Dec 10; 11(12):14-9. PubMed ID: 2866866 [Abstract] [Full Text] [Related]
14. [Conservative therapy of ulcerative colitis and Crohn disease]. Rasenack J, Kreisel W. Fortschr Med; 1991 Apr 10; 109(11):245-7. PubMed ID: 1855750 [Abstract] [Full Text] [Related]
15. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation]. MMW Fortschr Med; 2009 May 07; 151(19):38-9. PubMed ID: 19827443 [No Abstract] [Full Text] [Related]
16. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Dig Liver Dis; 2005 Jun 07; 37(6):407-17. PubMed ID: 15893279 [Abstract] [Full Text] [Related]